New NCCN Guidelines: Cancer Management in People Living With HIV

Author: Gita Suneja MD, MSHP 1
View More View Less
  • 1 Presented by Gita Suneja, MD, MSHP, Department of Radiation Oncology and Duke Global Health Institute, Duke University School of Medicine, Durham, North Carolina.
Restricted access

Since the emergence of HIV in the United States in the 1980s, cancer has been a part of the story. The good news is that antiretroviral therapy has improved survival for those living with HIV infection, with life expectancy now approaching that of uninfected people. Consequently, this patient population is living long enough to develop different types of cancer. At the 23rd NCCN Annual Conference, Gita Suneja, MD, MSHP, presented the debut of the new NCCN Guidelines for Cancer in People Living With HIV, discussing the intersection between cancer and HIV infection, the cancers most likely to develop in this group of patients, and the importance of oncologists working in conjunction with HIV specialists to render the most appropriate and individualized care.

Correspondence: Gita Suneja, MD, MSHP, Department of Radiation Oncology and Duke Global Health Institute, Duke University School of Medicine, 30 Duke Medicine Circle, Box 3085, Durham, NC 27710. Email:
  • 1.

    Suneja G, Boyer M, Yehia BR. Cancer treatment in patients with HIV infection and non-AIDS-defining cancers: a survey of US oncologists. J Oncol Pract 2015;11:e380387.

    • Search Google Scholar
    • Export Citation
  • 2.

    Engels EA, Pfeiffer RM, Goedert JJ. Trends in cancer risk among people with AIDS in the United States 1980-2002. AIDS 2006;20:16451654.

  • 3.

    Robbins HA, Pfeiffer RM, Shiels MS. Excess cancers among HIV-infected people in the United States. J Natl Cancer Inst 2015;107:pii: dju503.

  • 4.

    Suneja G, Shiels MS, Melville SK. Disparities in the treatment and outcomes of lung cancer among HIV-infected individuals. AIDS 2013;27:459468.

    • Search Google Scholar
    • Export Citation
  • 5.

    Persad GC, Little RF, Grady C. Including persons with HIV infection in cancer clinical trials. J Clin Oncol 2008;26:10271032.

  • 6.

    Uldrick TS, Ison G, Rudek MA. Modernizing clinical trial eligibility criteria: recommendations of the American Society of Clinical Oncology-Friends of Cancer Research HIV Working Group. J Clin Oncol 2017;35:37743780.

    • Search Google Scholar
    • Export Citation
  • 7.

    Spitzer TR, Ambinder RF, Lee JY. Dose-reduced busulfan, cyclophosphamide, and autologous stem cell transplantation for human immunodeficiency virus-associated lymphoma: AIDS Malignancy Consortium study 020. Biol Blood Marrow Transplant 2008;14:5966.

    • Search Google Scholar
    • Export Citation
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 481 169 6
PDF Downloads 121 69 8
EPUB Downloads 0 0 0